Ledger.Open graph →
SEC Form D · filed July 11, 2016

Prelude Therapeutics Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWARK, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Krishna Vaddi · Chadds Ford, PAExec · DirectorPaul Friedman · New York, NYDirectorDavid Bonita · Montreal, Quebec, CanadaDirectorKrishna Vaddi · Chadds Ford, PAExec · DirectorPaul Friedman · San Francisco, CADirectorDavid Bonita · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗